CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	47.35B +33.1%
Revenue (ttm)	2.09B +0.7%
Net Income	-109.65M
EPS	-0.08
Shares Out	1.39B
PE Ratio	n/a
Forward PE	74.77
Dividend	0.02 (0.06%)
Ex-Dividend Date	May 29, 2025

Volume	10,534,180
Average Volume	13,968,226
Open	34.49
Previous Close	34.67
Day's Range	33.91 - 35.44
52-Week Range	26.36 - 63.31
Beta	0.36
RSI	40.12
Earnings Date	Mar 17, 2026

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,487
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2024, SHE:300765's revenue was 1.98 billion, a decrease of -21.98% compared to the previous year's 2.54 billion. Earnings were 53.73 million, a decrease of -87.63%.